Dr Shafiq Khan Lab Transforming Growth Factor beta (TGF-  ) signaling How TGF-  promotes tumor progression The role of the different TGF-  isoforms.

Slides:



Advertisements
Similar presentations
The IndianaCTSI Biorepository is committed to serving the repository needs for CTSI investigators. The core will tailor specimen management to the needs.
Advertisements

Tyrosine kinase signalling (review) TGF signalling Notch signalling.
Ancha Baranova George Mason University, Fairfax, VA
Gene regulation in cancer 11/14/07. Overview The hallmark of cancer is uncontrolled cell proliferation. Oncogenes code for proteins that help to regulate.
Cell Identity Determined by types and amounts of proteins in the cell
Figure 13.2 The Biology of Cancer (© Garland Science 2007) Hodgkins Lymphoma – A Cancer in Which 99% of the Tumor Cells Are Not Cancer Cells.
BRCA1 The First Breast Cancer Gene Presentation By Liz Mosley.
Gene therapy progress and prospects cancer. Gene Therapy Primary challenge for gene therapy – Successfully delivery an efficacious dose of a therapeutic.
Chapter 20 oncogene, anti-oncogene and growth factor The biochemistry and molecular biology department of CMU.
Inhibition of SHH signaling enhances Docetaxel efficacy in castration-resistant prostate cancer cells Sierra L. Lawhorne 1,2, Sakthivel Muniyan 1, Parthasarathy.
Comprehensive Gene Expression Analysis of Prostate Cancer Reveals Distinct Transcriptional Programs Associated With Metastatic Disease Kevin Paiz-Ramirez.
Welcome to the Fall 2010 TBPT Meeting Dr. Paul Klotman President and CEO Baylor College of Medicine November 3, 2010.
Introduction to the NIH Grants System
Malignant Melanoma and CDKN2A
Cancer What is cancer? How does it form? How can it be treated?
Bioinformatics.
SC430 Molecular Cell Biology
States’ Investments in Cancer Research The Cancer Institute of New Jersey Robert S. DiPaola M.D.
Mission-Based Management December 2004 Electronic CV System Users Group.
Genome British Columbia. OUR VISION To be amongst the leaders worldwide in using innovative approaches to bringing the benefits of genomics to socio-economic.
Calculus and Cancer Drug Development Studies Stephan Gysin, PhD UCSF Helen Diller Family Comprehensive Cancer Center.
Department of Health and Human Services National Institutes of Health National Center for Research Resources Division of Research Infrastructure Extending.
Working Together to Work Wonders. The University of Texas Medical Branch Research: Advancing Knowledge, Improving Health David L. Callender, MD, MBA, FACS.
The Cancer Systems Biology Consortium (CSBC)
©Edited by Mingrui Zhang, CS Department, Winona State University, 2008 Identifying Lung Cancer Risks.
1 Bio-Trac 40 (Protein Bioinformatics) October 8, 2009 Zhang-Zhi Hu, M.D. Associate Professor Department of Oncology Department of Biochemistry and Molecular.
SHIP protein identified as a B-cell tumor suppressor Lymphoma is a cancer of the immune system. White blood cells divide again and again, spreading abnormally.
DEREK KENYENSO MENTOR: DR. JAYA SATAGOPAN HOSPITAL: MSKCC DEPARTMENT: EPIDEMIOLOGY/BIOSTTISTICS.
Expanding Biomedical Research in Maine Mount Desert Island Biological Laboratory Patricia H. Hand, Ph.D. Administrative Director.
Kelvin K. Tsai, M.D., Ph.D. Laboratory for Tumor Epigenetics and Stemness (TES Lab) NATIONAL INSTITUTE OF CANCER RESEARCH NATIONAL HEALTH RESEARCH INSTITUTES.
The role of sirtuin 3 in the differential pro-oxidant effects of (-)-epigallocatechin-3-gallate in oral cells Good morning, I am Ling Tao from Dr. Lambert’s.
Moein Farshchian Ph.D Candidate of Cell and Molecular Biology.
Laboratory Careers Packet #4. Introduction Individuals working in this field have various tasks, duties, interests and abilities. Laboratory personnel.
Genetic Repositories Australia BACKGROUND GRA supported by an NHMRC Enabling Facility Grant awarded in  GRA supported by an NHMRC Enabling Facility.
Regulation of Gene Expression. You Must Know The functions of the three parts of an operon. The role of repressor genes in operons. The impact of DNA.
P57, Tumorigenesis, and Beckwith-Wiedemann Syndrome Ashley Albright.
Potential therapeutic target & predictive biomarker Oncogenic IGFBP2 Sonya Song ( 宋韦 ) Beijing Shijitan Hospital Department of Oncology The Capital Medical.
GeneGroupAnalysis BetaCS Alejandro Quiroz-Zárate John Quackenbush lab
OMICS International welcomes submissions that are original and technically so as to serve both the developing world and developed countries in the best.
oncogene, anti-oncogene and growth factor
Archived File The file below has been archived for historical reference purposes only. The content and links are no longer maintained and may be outdated.
INTERACTION BETWEEN TUMOR & ITS MICROENVIRONMENT AVNER FRIEDMAN Mathematical Biosciences Institute Ohio State University, Columbus, USA.
CHAPTER 19 THE ORGANIZATION AND CONTROL OF EUKARYOTIC GENOMES Copyright © 2002 Pearson Education, Inc., publishing as Benjamin Cummings Section D: The.
Training. Intro to HEALTHeLINK HEALTHeLINK, the Western New York Clinical Information Exchange (WNYCIE), is a Regional Health Information Organization.
Regulation of gene expression by mutant and
Modeling the cell cycle regulation by the RB/E2F pathway Laurence Calzone Service de Bioinformatique U900 Inserm / Ecoles de Mines / Institut Curie Collaborative.
Host Defense Against Tumors (Tumor Immunity)
Biomedical Research, Health Disparities and the Digital Divide: Programs at the NCRR Susan R. Kayar, Ph.D. Division of Research Infrastructure.
Cancer Cancer- a malignant tumor; the result of abnormal cell proliferation. Regulation of Cell Division –Tumor Supressor Genes Genes that inhibit cell.
BERAC April 2004 Radiopharmaceutical Sub- committee Report.
NCI Division of Cancer Prevention Ongoing Activities at Frederick Facilities Presented By: Lori Minasian, M.D. Robert Shoemaker, Ph.D. October 1, 2015.
Cancer. Cancer is a disease of the cell cycle Caused by one or more of the following: Increase in growth signals Loss of inhibitory signals In addition,
Cancer The biological formation of cancer and treatments for the disease.
Tumor-suppressor genes Tumor-suppressor genes, function like brakes, keep cell numbers down, either by inhibiting progress through.
Yale SPORE in Skin Cancer
Can Drug Discovery Research be Done At An Undergraduate Institution?
Gregory Cooper Professor of Biomedical Informatics Director, Center for Causal Discovery Vice Chair Research, Department of Biomedical Informatics.
Cancer as a genetic disease
Figure 2 Crosstalk between TGF-β/Smad and other pathways in tissue fibrosis Figure 2 | Crosstalk between TGF-β/Smad and other pathways in tissue fibrosis.
Determining Key “Stemness” Genes
Molecular Basis Of Cancer
Inflammation and Colon Cancer
The Multifaceted Role of the Intestinal Microbiota in Colon Cancer
Cancer.
Mesenchymal Cells in Colon Cancer
Metastasis-Promoting Immunity: When T Cells Turn to the Dark Side
ID Proteins Regulate Diverse Aspects of Cancer Progression and Provide Novel Therapeutic Opportunities  Radhika Nair, Wee Siang Teo, Vivek Mittal, Alexander.
The Dual Role of Bone Morphogenetic Proteins in Cancer
Intratumoral hypoxia, radiation resistance, and HIF-1
Khalid S. Mohammad, Theresa A. Guise  Cancer Cell 
Presentation transcript:

Dr Shafiq Khan Lab Transforming Growth Factor beta (TGF-  ) signaling How TGF-  promotes tumor progression The role of the different TGF-  isoforms

Dr Jaideep Chaudhary Lab Inhibitors of Differentiation (Id) Promotes tumor progression Viruses causing prostate cancer Pathway of action

Dr Valerie Odero-Marah Lab Snail transcription factor Promotes tumor progression via reactive oxygen species Promotes metastasis to bone

Dr. Cimona V. Hinton Lab PTEN and CXCR4 Studying how loss of tumor suppressors permits metastasis enhancing genes. PTEN usually lost early in cancer progression CXCR4 associated with metastasis

Dr Godwin Ananaba Lab Role of Sterols in prostate cancer How high cholesterol and low phytosterol can promote prostate cancer Using cyclodextran compounds as a delivery system

Sources of Funding  National Institute of Health (NIH): RCMI, P20  National Cancer Institute (NCI): RO1  Department of Defense (DOD): Idea, New Investigator, Pca Training Grant  Georgia Research Alliance (GRA): equipment and personnel

Publications and Presentations  May 2009-April 2010: 11 journal articles  50 presentations in national meetings

Research Facilities  Molecular Biology  Cell Biology  Structural Biology  Histology  Bioinformatics and Biostatistics  Analytical

Collaborative Center for Cancer Genomics (CCGC)  Collaborative effort between Clark Atlanta University and Ovarian Cancer Institute at Georgia Tech  Gene expression analysis of individual patients

Prostate Cancer Tissue Bank  Collaboration between Saint Joseph’s hospital and Georgia Tech  Intend to acquire prostate cancer patient samples for analysis at the Genomics center  Intend to establish a prostate cancer tissue bank